Speaker(s): 

Zachary Adamchick, PharmD, Inpatient Pharmacist - has nothing to disclose 

Heather Hillhouse, RPH, Inpatient Pharmacist - has nothing to disclose 

Moderator(s): 

Sarah Hale, Pharm.D., BCPPS. Director of Pharmacy, Geisinger-has nothing to disclose 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Compare treatment options for coagulopathic bleeding in cardiac surgery​

• Review procedure on Geisinger’s Best Practice Guideline for non-approved K-Centra indications

• Describe the rationale for using tirofiban in AIS with mechanical thrombectomy.

• Interpret key safety and efficacy outcomes from the meta-analysis.

• Apply findings to clinical pharmacy practice.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Brain Simpkins, PharmD, Jessica Milheim, CPhT, and Tiffany Tang, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None